-
Delivered Solid Operating Results and Strong Free Cash Flow
-
Realizing Strategic Benefits of Merger; On Track to Meet $1 Billion
Annualized Synergy and Performance Improvements Objective by the End
of Fiscal 2018
NORCROSS, Ga.--(BUSINESS WIRE)--Jan. 28, 2016--
WestRock Company (WestRock) (NYSE: WRK) today announced results for its
fiscal first quarter ended December 31, 2015. Due to the $478 million
non-cash goodwill impairment charge associated with the Specialty
Chemicals segment, WestRock recorded a loss of $1.76 per diluted share
and adjusted earnings of $0.59 per diluted share.
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
December 31, 2015
|
|
|
|
|
|
Loss per diluted share
|
|
$
|
(1.76)
|
|
|
|
|
|
Restructuring and other items
|
|
|
0.49
|
|
Merger and acquisition inventory step-up expense
|
|
|
0.01
|
|
Impairment of Specialty Chemicals goodwill
|
|
|
1.86
|
|
Adjustment to reflect adjusted earnings on a fully diluted basis
|
|
|
(0.01)
|
|
|
|
|
|
Adjusted earnings per diluted share
|
|
$
|
0.59
|
|
|
|
|
“We continued to make excellent progress toward building the premier
global packaging company that we envisioned when we announced the
strategic combination of RockTenn and MeadWestvaco just one year ago,”
said Steve Voorhees, chief executive officer of WestRock. “This quarter
we delivered strong cash flows and made strategic investments to
position our business for growth, while maintaining our disciplined and
balanced capital allocation strategy. WestRock is realizing the
strategic benefits of the merger, having already achieved an annual run
rate of over $250 million of synergies and performance improvements, and
we remain on track to meet our $1 billion objective by the end of fiscal
2018.”
Net sales for WestRock for the quarter ended December 31, 2015, were
$3.68 billion and segment income was $279 million. Adjusted segment
income was $284 million, excluding the pre-tax impact of expensing $5
million of inventory that was stepped-up to fair value in purchase
accounting, net of related LIFO.
Restructuring and other items included $138 million of pre-tax facility
closure costs, which primarily related to the previously announced
permanent closure of the Coshocton, Ohio, medium mill and the Newberg,
Oregon, mill; $21 million of pre-tax integration expenses primarily
including severance and other costs primarily associated with the
merger; $12 million of operating losses and transition costs primarily
associated with operations in the process of being closed; $8 million of
pre-tax costs associated with the planned spin-off of our Specialty
Chemicals business into a new public company, Ingevity; $4 million of
acquisition expenses; and $3 million of start-up costs at the Specialty
Chemicals carbon facility in China.
The Company re-assessed the valuation of the Specialty Chemicals
business in light of changing market conditions and lower comparative
market valuations for companies in their peer group, and reduced the
estimated enterprise value to approximately $1.6 billion. As a result,
the Company recorded a pre-tax and after-tax goodwill impairment charge
of $478 million. WestRock is continuing with the spin of Ingevity, and
anticipates completion by early May, later than previously announced due
to the inherent complexities of the separation process.
Presentation of Financial Statements
On July 1, 2015, Rock-Tenn Company (RockTenn) and MeadWestvaco
Corporation (MeadWestvaco) completed a strategic combination of their
respective businesses. After completion of this transaction, RockTenn
and MeadWestvaco became wholly owned subsidiaries of WestRock. RockTenn
was the accounting acquirer in the transaction with MeadWestvaco,
therefore, unless otherwise indicated, the financial statements included
in this release beginning on page seven reflect only the results of
RockTenn for fiscal periods prior to the transaction. WestRock’s
consolidated financial statements include the consolidated results of
the new company WestRock for periods following the transaction.
The results disclosed in this release as “Combined” for the prior year
period beginning on page two do not reflect WestRock’s pro forma results
on a GAAP basis but rather represent the addition of RockTenn and
MeadWestvaco’s individual results for the quarter ended December 31,
2014. MeadWestvaco’s results have been recast for changes to charge the
MeadWestvaco segments for items such as additional corporate costs,
pension service costs and stock-based compensation in order to be
consistent with WestRock’s methodology, as well as to remove interest
expense and other income, net from MeadWestvaco’s Corporate and Other
category. The combined results for RockTenn and MeadWestvaco in this
release for the quarter ended December 31, 2014, also do not reflect the
effect of any purchase accounting adjustments, including but not limited
to the elimination of intercompany sales and the fair value of assets
and liabilities. In the tables below, Segment EBITDA is computed as
Segment Income plus Depreciation and Amortization. See Non-GAAP
Financial Measures and Reconciliations beginning on page eleven.
Consolidated Financial Results
The financial results below illustrate the performance of WestRock and
the combined performance of RockTenn and MeadWestvaco (as described
above) for the quarter ended December 31, 2015, and December 31, 2014,
respectively (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
3,680.7
|
|
$
|
3,888.3
|
|
$
|
(207.6
|
)
|
|
Adjusted Segment EBITDA including Non-Allocated expenses (1)
|
|
$
|
573.7
|
|
$
|
641.7
|
|
$
|
(68.0
|
)
|
|
Depreciation
|
|
$
|
223.5
|
|
$
|
203.9
|
|
$
|
19.6
|
|
|
Amortization
|
|
$
|
70.8
|
|
$
|
39.1
|
|
$
|
31.7
|
|
|
Adjusted Segment Income including Non-Allocated expenses (1)
|
|
$
|
279.4
|
|
$
|
398.7
|
|
$
|
(119.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Adjusted Segment EBITDA and Adjusted Segment Income exclude $4.8
million and $1.1 million pre-tax expense for inventory stepped-up in
purchase accounting, net of related LIFO, in the quarters ended
December 31, 2015 and 2014, respectively.
|
|
|
|
|
The $208 million decline in net sales compared to the combined prior
year period was primarily attributable $125 million due to foreign
currency translations, $41 million for the reduction in net sales in the
Consumer Packaging segment due to MeadWestvaco’s sale of its European
tobacco converting business in fiscal 2015, prior to the merger, $31
million of specialty chemicals sales and $30 million of lower Land and
Development net sales primarily related to forestland sales that
occurred in the prior year quarter. In addition, approximately $119
million of net sales related to the SP Fiber and Carolina brand
acquisitions were offset by $118 million in declines in volume, price
and mix in our Corrugated and Consumer Packaging businesses.
Adjusted Segment EBITDA declined by $68 million compared to the prior
year quarter due to the $29 million decline in Specialty Chemicals, the
$25 million decline in the Land and Development business and a reduction
in pension income of $29 million. Adjusted Segment EBITDA of our core
Consumer and Corrugated Packaging businesses and corporate expenses
excluding pension income, increased by $15 million due to our synergy
and performance improvements more than offsetting the decline in volume,
price and the net impact of deflation.
Non-Allocated Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Non-Allocated Expenses excluding Non-Service Pension Income
|
|
$
|
26.8
|
|
|
$
|
48.0
|
|
|
$
|
(21.2
|
)
|
|
Non-Service Pension Income
|
|
$
|
(22.3
|
)
|
|
$
|
(47.0
|
)
|
|
$
|
24.7
|
|
|
Non-Allocated Expenses as reported
|
|
$
|
4.5
|
|
|
$
|
1.0
|
|
|
$
|
3.5
|
|
|
|
|
|
|
|
|
|
Non-Allocated Expenses excluding non-service pension income decreased
$21 million compared to the prior year quarter due to cost reductions
and increased allocation of costs to our segments. Non-service pension
income associated with our qualified and nonqualified defined benefit
pension plans declined by $25 million. The decrease in non-service
pension income compared to the prior year quarter was primarily due to
the lower expected return on asset assumption that management
established in the fourth quarter of fiscal 2015 as a result of the U.S.
Qualified Pension Plans investment de-risking implemented in
anticipation of the merging of certain RockTenn and MeadWestvaco pension
plans at that time.
Segment Results
Corrugated Packaging
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Segment Sales
|
|
$
|
1,964.3
|
|
$
|
1,982.0
|
|
$
|
(17.7
|
)
|
|
Adjusted Segment EBITDA (1)
|
|
$
|
324.8
|
|
$
|
339.8
|
|
$
|
(15.0
|
)
|
|
Depreciation
|
|
$
|
121.7
|
|
$
|
107.1
|
|
$
|
14.6
|
|
|
Amortization
|
|
$
|
22.4
|
|
$
|
23.1
|
|
$
|
(0.7
|
)
|
|
Adjusted Segment Income (1)
|
|
$
|
180.7
|
|
$
|
209.6
|
|
$
|
(28.9
|
)
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Adjusted Segment EBITDA and Adjusted Segment Income in the quarter
ended December 31, 2015 exclude $0.6 million pre-tax expense for
inventory stepped-up in purchase accounting.
|
|
|
|
|
Operating Highlights for the Quarter Ended
December 31, 2015:
-
North American corrugated Adjusted EBITDA margin of 17.7%; Brazil
corrugated Adjusted EBITDA margin of 24.8%
-
North American box shipments increased 2.9% compared to the prior year
quarter; pricing stable over the prior year quarter
-
Corrugated Packaging segment shipments in North America were 2.05
million tons in the quarter ended December 31, 2015; an increase of
51,000 tons from the prior year quarter
-
Economic downtime of 144,000 tons and maintenance downtime of 120,000
tons; the economic downtime tons exclude 40,000 tons of containerboard
related to the Newberg mill closure in the December quarter
-
Incurred pre-tax operating losses of $7 million associated with
operating the Newberg mill in the quarter ended December 31, 2015
Period Comparability Items:
-
The impact of foreign exchange on Corrugated Packaging segment sales
and income for the quarter ended December 31, 2015 was unfavorable $80
million and $14 million, respectively
Consumer Packaging
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Segment Sales
|
|
$
|
1,542.2
|
|
$
|
1,669.2
|
|
$
|
(127.0
|
)
|
|
Adjusted Segment EBITDA (1)
|
|
$
|
218.5
|
|
$
|
210.3
|
|
$
|
8.2
|
|
|
Depreciation
|
|
$
|
87.8
|
|
$
|
87.9
|
|
$
|
(0.1
|
)
|
|
Amortization
|
|
$
|
37.3
|
|
$
|
10.1
|
|
$
|
27.2
|
|
|
Adjusted Segment Income (1)
|
|
$
|
93.4
|
|
$
|
112.3
|
|
$
|
(18.9
|
)
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Adjusted Segment EBITDA and Adjusted Segment Income in the quarter
ended December 31, 2015 and 2014 exclude $2.2 million and $1.1
million pre-tax expense, respectively, for inventory stepped-up in
purchase accounting, net of related LIFO.
|
|
|
|
|
Operating Highlights for the Quarter Ended
December 31, 2015:
-
Consumer Packaging segment year-over-year Adjusted EBITDA margin
growth of 160 basis points
-
Solid demand in folding carton and beverage packaging
-
Merchandising displays softness in customer promotional spending
during the quarter
-
Home, health and beauty business delivered strong EBITDA margin growth
due to favorable product mix, lower input costs and improved
productivity
-
Exited certain non-core international operations which incurred $4
million of pre-tax losses during the quarter
Period Comparability Items:
-
The impact of foreign exchange on Consumer Packaging segment sales and
income for the quarter ended December 31, 2015, was an unfavorable $45
million and $3 million, respectively
-
The quarter ended December 31, 2014, included $41 million and $3
million of sales and segment income, respectively, related to the
legacy MeadWestvaco European tobacco converting business that was sold
in fiscal 2015 prior to the merger
Specialty Chemicals
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Segment Sales
|
|
$
|
209.8
|
|
$
|
241.0
|
|
$
|
(31.2
|
)
|
|
Adjusted Segment EBITDA (1)
|
|
$
|
31.8
|
|
$
|
60.5
|
|
$
|
(28.7
|
)
|
|
Depreciation
|
|
$
|
12.0
|
|
$
|
7.2
|
|
$
|
4.8
|
|
|
Amortization
|
|
$
|
10.7
|
|
$
|
1.6
|
|
$
|
9.1
|
|
|
Adjusted Segment Income (1)
|
|
$
|
9.1
|
|
$
|
51.7
|
|
$
|
(42.6
|
)
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Adjusted Segment EBITDA and Adjusted Segment Income in the quarter
ended December 31, 2015 exclude $2.0 million pre-tax expense for
inventory stepped-up in purchase accounting, net of related LIFO.
|
|
|
|
|
Operating Highlights for the Quarter Ended
December 31, 2015:
-
Record December quarter sales for activated carbon and calendar year
sales of activated carbon and asphalt additive products
-
Significantly higher plant outage and other costs in the quarter
compared to the prior year quarter
-
Oilfield chemicals sales down significantly due to reduced oilfield
drilling and production activity
-
Pricing and volume pressure in certain industrial specialties markets
due to competitive materials
-
New activated carbon plant in China started trial production runs
during the quarter; start-up costs of $3 million pre-tax; segment
expects to realize sales in the first half of calendar 2016
Period Comparability Items:
-
The impact of foreign exchange on Specialty Chemicals segment sales
and income for the quarter ended December 31, 2015, was an unfavorable
$5 million and favorable $1 million, respectively
Land and Development
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined
|
|
|
|
|
|
Dec. 31, 2015
|
|
Dec. 31, 2014
|
|
Change
|
|
|
|
|
|
|
|
|
|
Segment Sales
|
|
$
|
15.4
|
|
$
|
44.9
|
|
$
|
(29.5
|
)
|
|
Segment EBITDA
|
|
$
|
1.4
|
|
$
|
26.5
|
|
$
|
(25.1
|
)
|
|
Depreciation
|
|
$
|
0.7
|
|
$
|
0.3
|
|
$
|
0.4
|
|
|
Amortization
|
|
$
|
-
|
|
$
|
0.1
|
|
$
|
(0.1
|
)
|
|
Segment Income
|
|
$
|
0.7
|
|
$
|
26.1
|
|
$
|
(25.4
|
)
|
|
|
|
|
|
|
|
|
Operating Highlights for the Quarter Ended
December 31, 2015:
-
Continuing strong economic and real estate trends in Charleston, SC
market
Period Comparability Items:
-
The prior year quarter included $37 million of forestland sales
-
Segment income in the quarter ended December 31, 2015, was impacted by
expensing $5 million of step-up in land values for items sold during
the period; the step-up in values occurred due to purchase accounting
and will impact future periods’ reported cost of sales
Cash Provided From Operating, Financing and
Investing Activities
Cash from operations was $523 million in the first quarter of fiscal
2016. Total debt was $5.82 billion at December 31, 2015. Total Funded
Debt (as defined) was $5.55 billion at December 31, 2015; our Leverage
Ratio (as defined) was 2.20 times. The primary difference between total
debt and Total Funded Debt is due to the inclusion of unamortized debt
stepped-up to fair value in purchase accounting and deferred financing
costs which are included in total debt.
During the first quarter of fiscal 2016, WestRock invested $282 million
in the previously announced acquisition of SP Fiber Holdings, Inc. net
of cash received and paid $37 million for debt owed by Green Power
Solutions of Georgia, LLC, a renewable energy joint venture providing
energy to Georgia Power and steam to the Dublin, Georgia, paper mill
acquired in the transaction.
The Company invested $204 million in capital expenditures, returned $94
million to our stockholders in stock repurchases and returned to
stockholders an additional $96 million in dividends.
Conference Call
The Company will host a conference call to discuss the results of
operations for the first quarter of fiscal 2016 and other topics that
may be raised during the discussion at 9:00 a.m., Eastern Time, on
January 29, 2016. The conference call will be webcast live with an
accompanying slide presentation, along with a copy of this press
release, at www.westrock.com.
Investors who wish to participate in the webcast via teleconference
should dial 888-790-4710 (inside the U.S.) or 773-756-0961 (outside the
U.S.) at least 15 minutes prior to the start of the call and enter the
passcode WESTROCK. Replays of the call will be available through March
5, 2016, and can be accessed at 866-351-2785 (U.S. callers) and
203-369-0055 (outside the U.S.).
About WestRock
WestRock (NYSE:WRK) aspires to be the premier partner and unrivaled
provider of paper and packaging solutions in consumer and corrugated
markets. WestRock's 41,000 team members support customers around the
world from more than 250 operating and business locations spanning North
America, South America, Europe and Asia. For more information, visit www.westrock.com.
Cautionary Statements
This release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are based on our current expectations, beliefs, plans or
forecasts and are typically identified by words or phrases such as
"may," "will," "could," "should," "would," "anticipate," "estimate,"
"expect," "project," "intend," "plan," "believe," "target," "prospects,"
"potential" and "forecast," and other words, terms and phrases of
similar meaning. Forward-looking statements involve estimates,
expectations, projections, goals, forecasts, assumptions, risks and
uncertainties. WestRock cautions readers that a forward-looking
statement is not a guarantee of future performance and that actual
results could differ materially from those contained in the
forward-looking statement. Such forward-looking statements include, but
are not limited to, statements regarding, among other things that we are
realizing the strategic benefits of the merger; we remain on track to
meet our $1 billion synergy and performance improvements objective by
the end of fiscal 2018; our Specialty Chemicals segment expects to
realize sales from our new activated carbon plant in China in the first
half of calendar 2016; and, with respect to our Land and Development
segment, step-up of land values will impact future periods. With respect
to these statements, WestRock has made assumptions regarding, among
other things, the results and impacts of the merger of MeadWestvaco and
RockTenn; whether and when the spin-off of WestRock's Specialty
Chemicals business will occur; economic, competitive and market
conditions generally; volumes and price levels of purchases by
customers; competitive conditions in WestRock's businesses and possible
adverse actions of their customers, competitors and suppliers. Further,
WestRock's businesses are subject to a number of general risks that
would affect any such forward-looking statements including, among
others, decreases in demand for their products; increases in energy, raw
materials, shipping and capital equipment costs; reduced supply of raw
materials; fluctuations in selling prices and volumes; intense
competition; the potential loss of certain customers; the scope, costs,
timing and impact of any restructuring of our operations and corporate
and tax structure; the occurrence of a natural disaster, such as a
hurricane, winter or tropical storm, earthquake, tornado, flood, fire,
or other unanticipated problems such as labor difficulties, equipment
failure or unscheduled maintenance and repair, which could result in
operational disruptions of varied duration; our desire or ability to
continue to repurchase company stock; and adverse changes in general
market and industry conditions. Such risks and other factors that may
impact management's assumptions are more particularly described in our
filings with the Securities and Exchange Commission, including Item 1A
“Risk Factors” in our Annual Report on Form 10-K for the fiscal year
ended September 30, 2015. The information contained herein speaks as of
the date hereof and WestRock does not have or undertake any obligation
to update or revise its forward-looking statements, whether as a result
of new information, future events or otherwise.
|
|
|
WestRock Company
|
|
Condensed Consolidated Statements of Income
|
|
In millions, except per share amounts (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
December 31,
|
|
|
|
2015
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
3,680.7
|
|
|
$
|
2,514.2
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
2,979.5
|
|
|
|
2,044.7
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
701.2
|
|
|
|
469.5
|
|
|
Selling, general and administrative, excluding intangible
amortization
|
|
|
363.7
|
|
|
|
221.3
|
|
|
Selling, general and administrative intangible amortization
|
|
|
64.2
|
|
|
|
22.4
|
|
|
Pension lump sum settlement and retiree medical curtailment, net
|
|
|
-
|
|
|
|
11.9
|
|
|
Restructuring and other costs, net
|
|
|
171.1
|
|
|
|
5.4
|
|
|
Impairment of Specialty Chemicals goodwill
|
|
|
478.3
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Operating profit (loss)
|
|
|
(376.1
|
)
|
|
|
208.5
|
|
|
Interest expense
|
|
|
(65.2
|
)
|
|
|
(23.3
|
)
|
|
Interest income and other income (expense), net
|
|
|
14.5
|
|
|
|
0.2
|
|
|
Equity in income of unconsolidated entities
|
|
|
1.3
|
|
|
|
2.2
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
(425.5
|
)
|
|
|
187.6
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
(26.2
|
)
|
|
|
(62.0
|
)
|
|
|
|
|
|
|
|
Consolidated net income (loss)
|
|
|
(451.7
|
)
|
|
|
125.6
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
(1.8
|
)
|
|
|
(0.5
|
)
|
|
|
|
|
|
|
|
Net income (loss) attributable to common
|
|
|
|
|
|
stockholders
|
|
$
|
(453.5
|
)
|
|
$
|
125.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computation of diluted earnings (loss) per share under the two-class
method
|
|
|
|
|
|
(in millions, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
$
|
(453.5
|
)
|
|
$
|
125.1
|
|
|
Less: Distributed and undistributed income
|
|
|
|
|
|
available to participating securities
|
|
|
-
|
|
|
|
(0.1
|
)
|
|
Distributed and undistributed income (loss) available
|
|
|
|
|
|
to common stockholders
|
|
$
|
(453.5
|
)
|
|
$
|
125.0
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding
|
|
|
257.6
|
|
|
|
142.8
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share
|
|
$
|
(1.76
|
)
|
|
$
|
0.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WestRock Company
|
|
Segment Information
|
|
In millions (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
December 31,
|
|
|
|
2015
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
$
|
1,964.3
|
|
|
$
|
1,842.8
|
|
|
Consumer Packaging
|
|
|
1,542.2
|
|
|
|
713.0
|
|
|
Specialty Chemicals
|
|
|
209.8
|
|
|
|
-
|
|
|
Land and Development
|
|
|
15.4
|
|
|
|
-
|
|
|
Intersegment Eliminations
|
|
|
(51.0
|
)
|
|
|
(41.6
|
)
|
|
|
|
|
|
|
|
Total net sales
|
|
$
|
3,680.7
|
|
|
$
|
2,514.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations before income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
$
|
180.1
|
|
|
$
|
184.9
|
|
|
Consumer Packaging
|
|
|
91.2
|
|
|
|
59.0
|
|
|
Specialty Chemicals
|
|
|
7.1
|
|
|
|
-
|
|
|
Land and Development
|
|
|
0.7
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Total segment income
|
|
$
|
279.1
|
|
|
$
|
243.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension lump sum settlement and retiree medical curtailment, net
|
|
|
-
|
|
|
|
(11.9
|
)
|
|
Restructuring and other costs, net
|
|
|
(171.1
|
)
|
|
|
(5.4
|
)
|
|
Impairment of Specialty Chemicals goodwill
|
|
|
(478.3
|
)
|
|
|
-
|
|
|
Non-allocated expenses
|
|
|
(4.5
|
)
|
|
|
(15.9
|
)
|
|
Interest expense
|
|
|
(65.2
|
)
|
|
|
(23.3
|
)
|
|
Interest income and other income (expense), net
|
|
|
14.5
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
Income (loss) from operations before income taxes
|
|
$
|
(425.5
|
)
|
|
$
|
187.6
|
|
|
|
|
|
|
|
|
|
|
WestRock Company
|
|
Condensed Consolidated Statements of Cash Flows
|
|
In millions (unaudited)
|
|
|
|
|
|
Three months ended December 31,
|
|
|
|
2015
|
|
2014
|
|
Cash flows from operating activities:
|
|
|
|
|
|
Consolidated net income (loss)
|
|
$
|
(451.7
|
)
|
|
$
|
125.6
|
|
|
Adjustments to reconcile consolidated net income (loss) to net cash
provided by operating activities:
|
|
|
|
Depreciation, depletion and amortization
|
|
|
294.3
|
|
|
|
151.8
|
|
|
Cost of real estate sold
|
|
|
9.3
|
|
|
|
-
|
|
|
Deferred income tax (benefit) expense
|
|
|
(20.5
|
)
|
|
|
58.9
|
|
|
Share-based compensation expense
|
|
|
11.8
|
|
|
|
10.7
|
|
|
(Gain) loss on disposal of plant and equipment and other, net
|
|
|
(0.5
|
)
|
|
|
0.6
|
|
|
Equity in income of unconsolidated entities
|
|
|
(1.3
|
)
|
|
|
(2.2
|
)
|
|
Pension and other postretirement funding (more) than expense (income)
|
|
|
(12.2
|
)
|
|
|
4.6
|
|
|
Cash surrender value increase in excess of premium paid
|
|
|
(10.0
|
)
|
|
|
-
|
|
|
Impairment adjustments and other non-cash items
|
|
|
108.5
|
|
|
|
(2.9
|
)
|
|
Impairment of Specialty Chemicals goodwill
|
|
|
478.3
|
|
|
|
-
|
|
|
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
|
|
Accounts receivable
|
|
|
228.6
|
|
|
|
94.8
|
|
|
Inventories
|
|
|
(59.5
|
)
|
|
|
(19.1
|
)
|
|
Other assets
|
|
|
16.0
|
|
|
|
(5.4
|
)
|
|
Accounts payable
|
|
|
(49.0
|
)
|
|
|
(51.5
|
)
|
|
Income taxes
|
|
|
30.5
|
|
|
|
(5.7
|
)
|
|
Accrued liabilities and other
|
|
|
(49.6
|
)
|
|
|
(27.8
|
)
|
|
Net cash provided by operating activities
|
|
|
523.0
|
|
|
|
332.4
|
|
|
Investing activities:
|
|
|
|
|
|
Capital expenditures
|
|
|
(203.8
|
)
|
|
|
(126.9
|
)
|
|
Cash paid for purchase of businesses, net of cash acquired
|
|
|
(281.7
|
)
|
|
|
-
|
|
|
Debt purchased in connection with an acquisition
|
|
|
(36.5
|
)
|
|
|
-
|
|
|
Investment in unconsolidated entities
|
|
|
(0.1
|
)
|
|
|
-
|
|
|
Return of capital from unconsolidated entities
|
|
|
0.1
|
|
|
|
0.2
|
|
|
Proceeds from the sale of subsidiary and affiliates
|
|
|
10.2
|
|
|
|
-
|
|
|
Proceeds from sale of property, plant and equipment
|
|
|
8.4
|
|
|
|
3.5
|
|
|
Net cash used for investing activities
|
|
|
(503.4
|
)
|
|
|
(123.2
|
)
|
|
Financing activities:
|
|
|
|
|
|
Additions to revolving credit facilities
|
|
|
121.9
|
|
|
|
39.4
|
|
|
Repayments of revolving credit facilities
|
|
|
(75.5
|
)
|
|
|
(58.7
|
)
|
|
Additions to debt
|
|
|
277.2
|
|
|
|
10.9
|
|
|
Repayments of debt
|
|
|
(143.8
|
)
|
|
|
(165.6
|
)
|
|
Commercial card program
|
|
|
(0.4
|
)
|
|
|
(0.4
|
)
|
|
Debt issuance costs
|
|
|
-
|
|
|
|
(0.1
|
)
|
|
Issuances of common stock, net of related minimum tax withholdings
|
|
|
5.4
|
|
|
|
1.8
|
|
|
Purchases of common stock
|
|
|
(94.3
|
)
|
|
|
(8.7
|
)
|
|
(Repayments to) advances from unconsolidated entity
|
|
|
(1.1
|
)
|
|
|
0.5
|
|
|
Cash dividends paid to stockholders
|
|
|
(96.4
|
)
|
|
|
(26.3
|
)
|
|
Cash distributions to noncontrolling interests
|
|
|
(2.8
|
)
|
|
|
(1.2
|
)
|
|
Net cash used for financing activities
|
|
|
(9.8
|
)
|
|
|
(208.4
|
)
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(1.2
|
)
|
|
|
(0.6
|
)
|
|
Increase in cash and cash equivalents
|
|
|
8.6
|
|
|
|
0.2
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
228.3
|
|
|
|
32.6
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
236.9
|
|
|
$
|
32.8
|
|
|
Supplemental disclosure of cash flow information
|
|
|
|
|
|
Cash paid during the period for:
|
|
|
|
|
|
Income taxes, net of refunds
|
|
$
|
23.4
|
|
|
$
|
8.8
|
|
|
Interest, net of amounts capitalized
|
|
|
19.2
|
|
|
|
5.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WestRock Company
|
|
Condensed Consolidated Balance Sheets
|
|
In millions (unaudited)
|
|
|
|
|
|
December 31, 2015
|
|
September 30, 2015
|
|
Assets
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
236.9
|
|
$
|
228.3
|
|
Restricted cash
|
|
|
7.3
|
|
|
7.3
|
|
Accounts receivable (net of allowances of $31.3 and $29.6)
|
|
|
1,491.0
|
|
|
1,690.0
|
|
Inventories
|
|
|
2,027.4
|
|
|
1,963.4
|
|
Other current assets
|
|
|
245.7
|
|
|
271.4
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
4,008.3
|
|
|
4,160.4
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
9,762.7
|
|
|
9,596.7
|
|
Goodwill
|
|
|
5,229.1
|
|
|
5,694.5
|
|
Intangibles, net
|
|
|
3,494.2
|
|
|
3,552.2
|
|
Restricted assets held by special purpose entities
|
|
|
1,298.7
|
|
|
1,302.1
|
|
Prepaid pension asset
|
|
|
530.4
|
|
|
532.9
|
|
Other assets
|
|
|
507.8
|
|
|
518.0
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
24,831.2
|
|
$
|
25,356.8
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
Current portion of debt
|
|
$
|
184.8
|
|
$
|
74.1
|
|
Accounts payable
|
|
|
1,313.7
|
|
|
1,303.8
|
|
Accrued compensation and benefits
|
|
|
275.6
|
|
|
358.0
|
|
Other current liabilities
|
|
|
475.0
|
|
|
427.3
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
2,249.1
|
|
|
2,163.2
|
|
|
|
|
|
|
|
Long-term debt due after one year
|
|
|
5,631.7
|
|
|
5,558.3
|
|
Pension liabilities, net of current portion
|
|
|
301.6
|
|
|
316.0
|
|
Postretirement medical liabilities, net of current portion
|
|
|
141.0
|
|
|
143.0
|
|
Non-recourse liabilities held by special purpose entities
|
|
|
1,176.7
|
|
|
1,179.6
|
|
Deferred income taxes
|
|
|
3,533.0
|
|
|
3,540.6
|
|
Other long-term liabilities
|
|
|
661.6
|
|
|
658.0
|
|
Redeemable noncontrolling interests
|
|
|
14.1
|
|
|
14.2
|
|
|
|
|
|
|
|
Total common stockholders' equity
|
|
|
10,975.7
|
|
|
11,651.8
|
|
Noncontrolling interests
|
|
|
146.7
|
|
|
132.1
|
|
Total Equity
|
|
|
11,122.4
|
|
|
11,783.9
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$
|
24,831.2
|
|
$
|
25,356.8
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures and
Reconciliations
|
|
|
|
We have included financial measures that were not prepared in
accordance with GAAP. Any analysis of non-GAAP financial measures
should be used only in conjunction with results presented in
accordance with GAAP. Below, we define the non-GAAP financial
measures, discuss the reasons that we believe this information is
useful to management and may be useful to investors, and provide
reconciliations of the non-GAAP financial measures to the most
directly comparable financial measures calculated in accordance with
GAAP. These measures may differ from similarly captioned measures of
other companies in our industry. The following non-GAAP measures are
not intended to be substitutes for GAAP financial measures and
should not be used as such.
|
|
|
|
Adjusted Segment EBITDA Margins
|
|
|
|
Our management uses “Adjusted Segment EBITDA Margins”, along with
other factors, to evaluate our segment performance against our
peers. Management believes that investors also use this measure to
evaluate our performance relative to our peers. “Adjusted Segment
EBITDA Margin” is calculated for each segment by dividing that
segment’s Adjusted Segment EBITDA by Adjusted Segment Sales.
|
|
|
|
Set forth below is a reconciliation of Adjusted Segment Sales,
Adjusted Segment EBITDA and Adjusted Segment EBITDA margins to the
most directly comparable GAAP measures, Segment Net Sales and
Segment Income for the quarter ended December 31, 2015 (in millions,
except percentages):
|
|
|
|
|
|
Corrugated
|
|
Consumer
|
|
Specialty
|
|
Land and
|
|
Corporate
|
|
|
|
|
|
Packaging
|
|
Packaging
|
|
Chemicals
|
|
Development
|
|
/ Other
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Net Sales
|
|
$
|
1,964.3
|
|
|
$
|
1,542.2
|
|
|
$
|
209.8
|
|
|
$
|
15.4
|
|
|
$
|
(51.0
|
)
|
|
$
|
3,680.7
|
|
|
Less: Trade Sales
|
|
|
(65.1
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(65.1
|
)
|
|
Adjusted Segment Sales
|
|
$
|
1,899.2
|
|
|
$
|
1,542.2
|
|
|
$
|
209.8
|
|
|
$
|
15.4
|
|
|
$
|
(51.0
|
)
|
|
$
|
3,615.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Income including Corporate
|
|
$
|
180.1
|
|
|
$
|
91.2
|
|
|
$
|
7.1
|
|
|
$
|
0.7
|
|
|
$
|
(4.5
|
)
|
|
$
|
274.6
|
|
|
Plus: Inventory Step-up
|
|
|
0.6
|
|
|
|
2.2
|
|
|
|
2.0
|
|
|
—
|
|
|
—
|
|
|
|
4.8
|
|
|
Adjusted Segment Income including Corporate
|
|
$
|
180.7
|
|
|
$
|
93.4
|
|
|
$
|
9.1
|
|
|
$
|
0.7
|
|
|
$
|
(4.5
|
)
|
|
$
|
279.4
|
|
|
Depreciation and Amortization
|
|
|
144.1
|
|
|
|
125.1
|
|
|
|
22.7
|
|
|
|
0.7
|
|
|
|
1.7
|
|
|
|
294.3
|
|
|
Adjusted Segment EBITDA
|
|
$
|
324.8
|
|
|
$
|
218.5
|
|
|
$
|
31.8
|
|
|
$
|
1.4
|
|
|
$
|
(2.8
|
)
|
|
$
|
573.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Segment EBITDA Margins
|
|
|
17.1
|
%
|
|
|
14.2
|
%
|
|
|
15.2
|
%
|
|
|
9.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North
American
Corrugated
|
|
|
Brazil
Corrugated
|
|
|
Other
|
|
|
Total
Corrugated
Packaging
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Net Sales
|
|
|
$
|
1,762.3
|
|
|
|
$
|
86.7
|
|
|
|
$
|
115.3
|
|
|
|
$
|
1,964.3
|
|
|
Less: Trade Sales
|
|
|
|
(65.1
|
)
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
(65.1
|
)
|
|
Adjusted Segment Sales
|
|
|
$
|
1,697.2
|
|
|
|
$
|
86.7
|
|
|
|
$
|
115.3
|
|
|
|
$
|
1,899.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Income
|
|
|
$
|
169.6
|
|
|
|
$
|
10.0
|
|
|
|
$
|
0.5
|
|
|
|
$
|
180.1
|
|
|
Plus: Inventory Step-up
|
|
|
|
0.5
|
|
|
|
|
0.1
|
|
|
|
|
―
|
|
|
|
|
0.6
|
|
|
Adjusted Segment Income
|
|
|
$
|
170.1
|
|
|
|
$
|
10.1
|
|
|
|
$
|
0.5
|
|
|
|
$
|
180.7
|
|
|
Depreciation and Amortization
|
|
|
|
130.0
|
|
|
|
|
11.4
|
|
|
|
|
2.7
|
|
|
|
|
144.1
|
|
|
Adjusted Segment EBITDA
|
|
|
$
|
300.1
|
|
|
|
$
|
21.5
|
|
|
|
$
|
3.2
|
|
|
|
$
|
324.8
|
|
|
Adjusted Segment EBITDA Margins
|
|
|
|
17.7
|
%
|
|
|
|
24.8
|
%
|
|
|
|
2.8
|
%
|
|
|
|
17.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement EBITDA and Total Funded
Debt
|
|
|
|
“Credit Agreement EBITDA” is calculated in accordance with the
definition contained in our Credit Agreement. Credit Agreement
EBITDA is generally defined as Consolidated Net Income plus:
consolidated interest expense, income taxes of the consolidated
companies determined in accordance with GAAP, depreciation and
amortization expense of the consolidated companies determined in
accordance with GAAP, loss on extinguishment of debt and financing
fees, certain non-cash and cash charges incurred, including goodwill
impairment charges, certain restructuring and other costs, merger,
acquisition and integration costs, charges and expenses associated
with the write-up of inventory acquired and other items.
|
|
|
|
“Total Funded Debt” is calculated in accordance with the definition
contained in our Credit Agreement. Total Funded Debt is generally
defined as aggregate debt obligations reflected in our balance
sheet, less the hedge adjustments resulting from terminated and
existing fair value interest rate derivatives or swaps, if any, less
certain cash, less the fair value of debt step-up remaining from the
merger and deferred financing costs, plus additional outstanding
letters of credit not already reflected in debt and certain
guarantees.
|
|
|
|
Our management uses Credit Agreement EBITDA and Total Funded Debt to
evaluate compliance with our debt covenants and borrowing capacity
available under our Credit Agreement and as a measure of operating
performance. Management believes that investors also use these
measures to evaluate our compliance with our debt covenants and
available borrowing capacity. Borrowing capacity is dependent upon,
in addition to other measures, the “Credit Agreement Debt/EBITDA
ratio” or the “Leverage Ratio,” which is defined as Total Funded
Debt divided by Credit Agreement EBITDA. As of the December 31, 2015
calculation, our Leverage Ratio was 2.20 times. While the Leverage
Ratio under the Credit Agreement determines the credit spread on our
debt we are not subject to a Leverage Ratio cap. The Credit
Agreement is subject to a Debt to Capitalization and Consolidated
Interest Coverage Ratio, as defined in the Credit Agreement. Our
management uses Credit Agreement EBITDA and Total Funded Debt to
evaluate our performance and to compare to our target Leverage Ratio
of 2.25x – 2.50x.
|
|
|
|
Set forth below is a reconciliation of Credit Agreement EBITDA for
the twelve months ended December 31, 2015, to the most directly
comparable GAAP measure, Consolidated Net Income (Loss):
|
|
|
|
|
|
|
(In Millions)
|
|
|
|
|
|
|
|
|
|
Consolidated Net Income (Loss)
|
|
|
$
|
(65.5
|
)
|
|
Interest Expense, net
|
|
|
|
130.8
|
|
|
Income Taxes
|
|
|
|
214.7
|
|
|
Depreciation, Depletion and Amortization
|
|
|
|
883.3
|
|
|
Additional Permitted Charges
|
|
|
|
1,361.3
|
|
|
Credit Agreement EBITDA
|
|
|
$
|
2,524.6
|
|
|
|
|
|
|
|
|
|
|
|
Additional Permitted Charges in the table above includes among other
items, the $478 million goodwill impairment charge for our Specialty
Chemicals business; $185 million and $265 million for MeadWestvaco
for the quarters ended March 30, 2015 and June 30, 2015,
respectively; $313 million of Restructuring and other costs, net and
$77 million pre-tax expense for inventory stepped-up in purchase
accounting.
|
|
|
|
Set forth below is a reconciliation of Total Funded Debt to the most
directly comparable GAAP measures, Current portion of debt and
Long-term debt due after one year as of December 31, 2015:
|
|
|
|
|
|
|
|
|
|
|
(In Millions, except ratio)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Portion of Debt
|
|
|
$
|
184.8
|
|
|
Long-Term Debt Due After One Year
|
|
|
|
5,631.7
|
|
|
Total Debt
|
|
|
|
5,816.5
|
|
|
Less: Unamortized Debt Stepped-up in Purchase Accounting and
Deferred Financing Costs
|
|
|
|
(321.1
|
)
|
|
Plus: Letters of Credit, Guarantees and Other Adjustments
|
|
|
|
50.0
|
|
|
Total Funded Debt
|
|
|
$
|
5,545.4
|
|
|
|
|
|
|
|
|
|
Credit Agreement EBITDA
|
|
|
$
|
2,524.6
|
|
|
|
|
|
|
|
|
|
Leverage Ratio
|
|
|
|
2.20
|
x
|
|
|
|
|
|
|
|
|
|
|
Adjusted Net Income and Adjusted Earnings
per Diluted Share
|
|
|
|
We also use the non-GAAP financial measures “adjusted net income”
and “adjusted earnings per diluted share”. Management believes these
non-GAAP financial measures provide our board of directors,
investors, potential investors, securities analysts and others with
useful information to evaluate our performance because it excludes
restructuring and other costs, net, and other specific items that
management believes are not indicative of the ongoing operating
results of the business. The Company and our board of directors use
this information to evaluate our performance relative to other
periods. We believe that the most directly comparable GAAP measures
to adjusted net income and adjusted earnings per diluted share are
Net income attributable to common stockholders and Earnings per
diluted share, respectively. Set forth below at the beginning of
this press release is a reconciliation of adjusted earnings per
diluted share to Earnings per diluted share. Set forth below is a
reconciliation of adjusted net income to Loss attributable to common
stockholders (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
December 31, 2015
|
|
|
|
|
|
|
|
Loss attributable to common stockholders
|
|
|
$
|
(453.5)
|
|
|
|
|
|
|
|
Restructuring and other items
|
|
|
|
125.6
|
|
Merger and acquisition inventory step-up expense
|
|
|
|
3.3
|
|
Impairment of Specialty Chemicals goodwill
|
|
|
|
478.3
|
|
|
|
|
|
|
|
Adjusted net income
|
|
|
$
|
153.7
|
|
|
|
|
|
|
|
|
|
The Combined RKT / MWV column in the table below represents the
addition of RockTenn and MeadWestvaco’s individual results for the
quarter ended December 31, 2014. MeadWestvaco’s results have been
recast for changes to charge the MeadWestvaco segments for items
such as additional corporate costs, pension service costs and
stock-based compensation in order to be consistent with WestRock’s
methodology, as well as to remove interest expense and other income,
net from MeadWestvaco’s Corporate and Other category, and does not
reflect the effect of any purchase accounting adjustments, including
but not limited to the elimination of intercompany sales and the
fair value of assets and liabilities and therefore do not reflect
WestRock’s pro forma results on a GAAP basis (in millions, except
percentages):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RKT (1)
|
|
|
MWV as
Reported (2)
|
|
|
MWV
Adjustments (3)
|
|
|
MWV
Recast Total
|
|
|
Combined
RKT / MWV
|
|
Segment Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
|
$
|
1,842.8
|
|
|
|
$
|
139.2
|
|
|
|
$
|
-
|
|
|
|
$
|
139.2
|
|
|
|
$
|
1,982.0
|
|
|
Consumer Packaging
|
|
|
|
713.0
|
|
|
|
|
956.2
|
|
|
|
|
-
|
|
|
|
|
956.2
|
|
|
|
|
1,669.2
|
|
|
Specialty Chemicals
|
|
|
|
-
|
|
|
|
|
241.0
|
|
|
|
|
-
|
|
|
|
|
241.0
|
|
|
|
|
241.0
|
|
|
Land & Development
|
|
|
|
-
|
|
|
|
|
44.9
|
|
|
|
|
-
|
|
|
|
|
44.9
|
|
|
|
|
44.9
|
|
|
Intersegment Eliminations
|
|
|
|
(41.6
|
)
|
|
|
|
(7.2
|
)
|
|
|
|
-
|
|
|
|
|
(7.2
|
)
|
|
|
|
(48.8
|
)
|
|
Total Segment sales
|
|
|
$
|
2,514.2
|
|
|
|
$
|
1,374.1
|
|
|
|
$
|
-
|
|
|
|
$
|
1,374.1
|
|
|
|
$
|
3,888.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Segment Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
|
$
|
184.9
|
|
|
|
$
|
27.2
|
|
|
|
$
|
(2.5
|
)
|
|
|
$
|
24.7
|
|
|
|
$
|
209.6
|
|
|
Consumer Packaging
|
|
|
|
60.1
|
|
|
|
|
84.4
|
|
|
|
|
(32.2
|
)
|
|
|
|
52.2
|
|
|
|
|
112.3
|
|
|
Specialty Chemicals
|
|
|
|
-
|
|
|
|
|
53.4
|
|
|
|
|
(1.7
|
)
|
|
|
|
51.7
|
|
|
|
|
51.7
|
|
|
Land & Development
|
|
|
|
-
|
|
|
|
|
12.2
|
|
|
|
|
13.9
|
|
|
|
|
26.1
|
|
|
|
|
26.1
|
|
|
Total Segment Income
|
|
|
|
245.0
|
|
|
|
|
177.2
|
|
|
|
|
(22.5
|
)
|
|
|
|
154.7
|
|
|
|
|
399.7
|
|
|
Non-Allocated Expenses
|
|
|
|
(15.9
|
)
|
|
|
|
(23.1
|
)
|
|
|
|
38.0
|
|
|
|
|
14.9
|
|
|
|
|
(1.0
|
)
|
|
Adjusted Segment Income including Non-Allocated Expenses
|
|
|
|
229.1
|
|
|
|
|
154.1
|
|
|
|
|
15.5
|
|
|
|
|
169.6
|
|
|
|
|
398.7
|
|
|
Noncontrolling interest
|
|
|
|
-
|
|
|
|
|
15.5
|
|
|
|
|
(15.5
|
)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
MWV Interest and Other Items
|
|
|
|
-
|
|
|
|
|
(73.0
|
)
|
|
|
|
-
|
|
|
|
|
(73.0
|
)
|
|
|
|
(73.0
|
)
|
|
|
|
|
$
|
229.1
|
|
|
|
$
|
96.6
|
|
|
|
$
|
-
|
|
|
|
$
|
96.6
|
|
|
|
$
|
325.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
|
$
|
120.0
|
|
|
|
$
|
10.2
|
|
|
|
$
|
-
|
|
|
|
$
|
10.2
|
|
|
|
$
|
130.2
|
|
|
Consumer Packaging
|
|
|
|
27.6
|
|
|
|
|
70.4
|
|
|
|
|
-
|
|
|
|
|
70.4
|
|
|
|
|
98.0
|
|
|
Specialty Chemicals
|
|
|
|
-
|
|
|
|
|
8.8
|
|
|
|
|
-
|
|
|
|
|
8.8
|
|
|
|
|
8.8
|
|
|
Land & Development
|
|
|
|
-
|
|
|
|
|
0.4
|
|
|
|
|
-
|
|
|
|
|
0.4
|
|
|
|
|
0.4
|
|
|
Total Segment D&A
|
|
|
|
147.6
|
|
|
|
|
89.8
|
|
|
|
|
-
|
|
|
|
|
89.8
|
|
|
|
|
237.4
|
|
|
Non-Allocated Expenses
|
|
|
|
4.2
|
|
|
|
|
1.4
|
|
|
|
|
-
|
|
|
|
|
1.4
|
|
|
|
|
5.6
|
|
|
Total D&A
|
|
|
$
|
151.8
|
|
|
|
$
|
91.2
|
|
|
|
$
|
-
|
|
|
|
$
|
91.2
|
|
|
|
$
|
243.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Segment EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
|
$
|
304.9
|
|
|
|
$
|
37.4
|
|
|
|
$
|
(2.5
|
)
|
|
|
$
|
34.9
|
|
|
|
$
|
339.8
|
|
|
Consumer Packaging
|
|
|
|
87.7
|
|
|
|
|
154.8
|
|
|
|
|
(32.2
|
)
|
|
|
|
122.6
|
|
|
|
|
210.3
|
|
|
Specialty Chemicals
|
|
|
|
-
|
|
|
|
|
62.2
|
|
|
|
|
(1.7
|
)
|
|
|
|
60.5
|
|
|
|
|
60.5
|
|
|
Land & Development
|
|
|
|
-
|
|
|
|
|
12.6
|
|
|
|
|
13.9
|
|
|
|
|
26.5
|
|
|
|
|
26.5
|
|
|
Total Adjusted Segment EBITDA
|
|
|
|
392.6
|
|
|
|
|
267.0
|
|
|
|
|
(22.5
|
)
|
|
|
|
244.5
|
|
|
|
|
637.1
|
|
|
Non-Allocated Expenses
|
|
|
|
(11.7
|
)
|
|
|
|
(21.7
|
)
|
|
|
|
38.0
|
|
|
|
|
16.3
|
|
|
|
|
4.6
|
|
|
Noncontrolling interest
|
|
|
|
-
|
|
|
|
|
15.5
|
|
|
|
|
(15.5
|
)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
Adjusted Segment EBITDA, including Non-Allocated Expenses
|
|
|
$
|
380.9
|
|
|
|
$
|
260.8
|
|
|
|
$
|
-
|
|
|
|
$
|
260.8
|
|
|
|
$
|
641.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Segment EBITDA Margins
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corrugated Packaging
|
|
|
|
16.5
|
%
|
|
|
|
26.9
|
%
|
|
|
|
nm
|
|
|
|
|
25.1
|
%
|
|
|
|
17.1
|
%
|
|
Consumer Packaging
|
|
|
|
12.3
|
%
|
|
|
|
16.2
|
%
|
|
|
|
nm
|
|
|
|
|
12.8
|
%
|
|
|
|
12.6
|
%
|
|
Specialty Chemicals
|
|
|
|
0.0
|
%
|
|
|
|
25.8
|
%
|
|
|
|
nm
|
|
|
|
|
25.1
|
%
|
|
|
|
25.1
|
%
|
|
Land & Development
|
|
|
|
0.0
|
%
|
|
|
|
28.1
|
%
|
|
|
|
nm
|
|
|
|
|
59.0
|
%
|
|
|
|
59.0
|
%
|
|
Adjusted Segment EBITDA Margins, including Non-Allocated
Expenses
|
|
|
|
15.1
|
%
|
|
|
|
19.0
|
%
|
|
|
|
nm
|
|
|
|
|
19.0
|
%
|
|
|
|
16.5
|
%
|
|
|
|
|
|
|
(1)
|
|
|
As adjusted for segment realignment, RockTenn's Consumer Packaging
segment excludes $1.1 million of inventory step-up
|
|
(2)
|
|
|
As adjusted for segment realignment and presented to one decimal
|
|
(3)
|
|
|
Recasting of allocation of additional Corporate, pension and
stock-based compensation costs to segments in order to conform to
the WestRock methodology.
|
|
|
|
|
|

View source version on businesswire.com: http://www.businesswire.com/news/home/20160128006555/en/
Source: WestRock Company
WestRock
Investor Relations:
John Stakel, SVP-Treasurer,
678-291-7901
Jason Thompson, Dir. of Investor Relations,
804-444-2556
or
Media:
Tucker McNeil, Dir. of Corporate
Communications, 804-444-6353